These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
611 related articles for article (PubMed ID: 20937530)
21. Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. Wenning W; Haghikia A; Laubenberger J; Clifford DB; Behrens PF; Chan A; Gold R N Engl J Med; 2009 Sep; 361(11):1075-80. PubMed ID: 19741228 [TBL] [Abstract][Full Text] [Related]
22. The human JC polyomavirus (JCPyV): virological background and clinical implications. Hirsch HH; Kardas P; Kranz D; Leboeuf C APMIS; 2013 Aug; 121(8):685-727. PubMed ID: 23781977 [TBL] [Abstract][Full Text] [Related]
23. Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy. Jelcic I; Combaluzier B; Jelcic I; Faigle W; Senn L; Reinhart BJ; Ströh L; Nitsch RM; Stehle T; Sospedra M; Grimm J; Martin R Sci Transl Med; 2015 Sep; 7(306):306ra150. PubMed ID: 26400911 [TBL] [Abstract][Full Text] [Related]
24. The pathogenesis of progressive multifocal leukoencephalopathy. Berger JR; Khalili K Discov Med; 2011 Dec; 12(67):495-503. PubMed ID: 22204766 [TBL] [Abstract][Full Text] [Related]
25. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. Langer-Gould A; Atlas SW; Green AJ; Bollen AW; Pelletier D N Engl J Med; 2005 Jul; 353(4):375-81. PubMed ID: 15947078 [TBL] [Abstract][Full Text] [Related]
26. Immunology of progressive multifocal leukoencephalopathy. Jelcic I; Jelcic I; Faigle W; Sospedra M; Martin R J Neurovirol; 2015 Dec; 21(6):614-22. PubMed ID: 25740538 [TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy. Bossolasco S; Calori G; Moretti F; Boschini A; Bertelli D; Mena M; Gerevini S; Bestetti A; Pedale R; Sala S; Sala S; Lazzarin A; Cinque P Clin Infect Dis; 2005 Mar; 40(5):738-44. PubMed ID: 15714422 [TBL] [Abstract][Full Text] [Related]
28. JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes? Diotti RA; Nakanishi A; Clementi N; Mancini N; Criscuolo E; Solforosi L; Clementi M Clin Dev Immunol; 2013; 2013():967581. PubMed ID: 23878587 [TBL] [Abstract][Full Text] [Related]
29. Progressive multifocal leukoencephalopathy revisited: Has the disease outgrown its name? Koralnik IJ Ann Neurol; 2006 Aug; 60(2):162-73. PubMed ID: 16862584 [TBL] [Abstract][Full Text] [Related]
30. New features of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy and natalizumab. Lima MA; Koralnik IJ J Neurovirol; 2005; 11 Suppl 3():52-7. PubMed ID: 16540456 [TBL] [Abstract][Full Text] [Related]
31. A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification. Lee P; Plavina T; Castro A; Berman M; Jaiswal D; Rivas S; Schlain B; Subramanyam M J Clin Virol; 2013 Jun; 57(2):141-6. PubMed ID: 23465394 [TBL] [Abstract][Full Text] [Related]
32. Cellular and humoral immune response in progressive multifocal leukoencephalopathy. Weber F; Goldmann C; Krämer M; Kaup FJ; Pickhardt M; Young P; Petry H; Weber T; Lüke W Ann Neurol; 2001 May; 49(5):636-42. PubMed ID: 11357954 [TBL] [Abstract][Full Text] [Related]
33. The basis for modeling progressive multifocal leukoencephalopathy pathogenesis. Berger JR Curr Opin Neurol; 2011 Jun; 24(3):262-7. PubMed ID: 21499097 [TBL] [Abstract][Full Text] [Related]
34. JC viral loads in patients with Crohn's disease treated with immunosuppression: can we screen for elevated risk of progressive multifocal leukoencephalopathy? Verbeeck J; Van Assche G; Ryding J; Wollants E; Rans K; Vermeire S; Pourkarim MR; Noman M; Dillner J; Van Ranst M; Rutgeerts P Gut; 2008 Oct; 57(10):1393-7. PubMed ID: 18436577 [TBL] [Abstract][Full Text] [Related]
35. Overview of the cellular immunity against JC virus in progressive multifocal leukoencephalopathy. Koralnik IJ J Neurovirol; 2002 Dec; 8 Suppl 2():59-65. PubMed ID: 12491153 [TBL] [Abstract][Full Text] [Related]
36. Analysis of the transcriptional control region of JC polyomavirus in cerebrospinal fluid from HIV-negative patients with progressive multifocal leucoencephalopathy. Fedele CG; Polo C; Tenorio A; Niubò J; Ciardi MR; Pérez JL J Med Virol; 2006 Oct; 78(10):1271-5. PubMed ID: 16927288 [TBL] [Abstract][Full Text] [Related]
38. Progressive multifocal leukoencephalopathy: report of three cases in HIV-negative hematological patients and review of literature. Pelosini M; Focosi D; Rita F; Galimberti S; Caracciolo F; Benedetti E; Papineschi F; Petrini M Ann Hematol; 2008 May; 87(5):405-12. PubMed ID: 18064459 [TBL] [Abstract][Full Text] [Related]
39. The link between VLA-4 and JC virus reactivation. Monaco MC; Major EO Expert Rev Clin Immunol; 2012 Jan; 8(1):63-72. PubMed ID: 22149341 [TBL] [Abstract][Full Text] [Related]
40. Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient. Balduzzi A; Lucchini G; Hirsch HH; Basso S; Cioni M; Rovelli A; Zincone A; Grimaldi M; Corti P; Bonanomi S; Biondi A; Locatelli F; Biagi E; Comoli P Bone Marrow Transplant; 2011 Jul; 46(7):987-92. PubMed ID: 20921942 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]